<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02938806</url>
  </required_header>
  <id_info>
    <org_study_id>#160113</org_study_id>
    <nct_id>NCT02938806</nct_id>
  </id_info>
  <brief_title>The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children</brief_title>
  <official_title>The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study employs a cross-sectional design to profile the gut microbiome and urine
      metabolome in overweight/obese children with type 1 diabetes (T1D).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will obtain stool and urine samples from subjects aged 7-17 years in 4
      groups:

        -  Group 1: Obese or overweight children within 3 years of diagnosis of T1D

        -  Group 2: Normal weight children within 3 years of diagnosis of T1D

        -  Group 3: Obese or overweight children without T1D

        -  Group 4: Normal weight children without T1D

      Type 1 diabetes will be defined according to American Diabetes Association criteria along
      with the presence of pancreatic autoantibodies (GAD65, ICA512, or insulin autoantibodies).
      Obese and overweight status will be defined by BMI &gt;85th percentile for age and gender
      according to CDC criteria.

      All subjects will provide one-time stool and first morning urine sample. Overweight or obese
      subjects will additionally have a point of care blood glucose and hemoglobin A1c measurement
      to ensure that they do not have diabetes.

      The investigators will perform 16S rRNA sequencing of stool bacteria and mass spectrometry
      measurement of urine metabolites.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of gut microbial composition and diversity by 16S rRNA sequencing</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of urine metabolite concentrations measured by mass spectrometry</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Obese/overweight children with T1D</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal weight children with T1D</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese/overweight children, no diabetes</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy, normal weight children</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Obese/overweight children with T1D</arm_group_label>
    <arm_group_label>Normal weight children with T1D</arm_group_label>
    <arm_group_label>Obese/overweight children, no diabetes</arm_group_label>
    <arm_group_label>Healthy, normal weight children</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool Urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children aged 7-17 years with/without T1DM and with/without obese/overweight status in San
        Diego, California
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 7 to 17 years

          -  Diagnosis of diabetes will be defined by current American Diabetes Association
             criteria ° (fasting glucose &gt; 126 mg/dl, 2 hour OGTT glucose &gt; 200 mg/dl; random
             glucose &gt; 200 with symptoms of hyperglycemia; or HbA1c &gt; 6.5%)

          -  Diabetes duration &lt; 3 years

          -  Presence of pancreatic autoimmunity (GAD65, ICA512, or insulin autoantibody
             positivity)

          -  Adult caregiver willing to actively support study participation

          -  Signed parental informed consent form and minor child informed assent form

        Exclusion Criteria:

          -  Other significant organ system illness or condition (including psychiatric or
             developmental disorder) that, in the opinion of the investigator, would prevent
             participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jane Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sejal Kadakia, MD</last_name>
    <phone>858-966-4032</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Rady Children's Hospital Endocrinology Department</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sejal Kadakia, MD</last_name>
      <email>skadakia@rchsd.org</email>
    </contact>
    <contact_backup>
      <last_name>Jane Kim, MD</last_name>
      <email>janekim@ucsd.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Boerner BP, Sarvetnick NE. Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann N Y Acad Sci. 2011 Dec;1243:103-18. doi: 10.1111/j.1749-6632.2011.06340.x. Review.</citation>
    <PMID>22211896</PMID>
  </reference>
  <reference>
    <citation>Dunne JL, Triplett EW, Gevers D, Xavier R, Insel R, Danska J, Atkinson MA. The intestinal microbiome in type 1 diabetes. Clin Exp Immunol. 2014 Jul;177(1):30-7. doi: 10.1111/cei.12321. Review.</citation>
    <PMID>24628412</PMID>
  </reference>
  <reference>
    <citation>Zimny D, Szatkowska M, Połubok J, Maciaszek J, Machaj M, Barg E. [The use of metabolomics in medicine - some examples of oncological and metabolic diseases]. Pediatr Endocrinol Diabetes Metab. 2015;20(2):55-62. doi: 10.18544/PEDM-20.02.0003. Review. Polish.</citation>
    <PMID>26615014</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2016</study_first_posted>
  <last_update_submitted>October 18, 2016</last_update_submitted>
  <last_update_submitted_qc>October 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Dr Jane Kim</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Gain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

